• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液复钙时间。一种监测肝素治疗的简单可靠的检测方法。

Blood recalcification time. A simple and reliable test to monitor heparin therapy.

作者信息

Gulliani G L, Hyun B H, Litten M B

出版信息

Am J Clin Pathol. 1976 Mar;65(3):390-6. doi: 10.1093/ajcp/65.3.390.

DOI:10.1093/ajcp/65.3.390
PMID:1258831
Abstract

The applicability of blood recalcification time as a laboratory test to assess and thereby regulate heparin anticoagulation was evaluated. Normal values for blood recalcification time ranged from 65 to 135 seconds, with a mean and standard deviation of 99 and 12 seconds, respectively. Duplicate determinations showed a mean variation of 5%. Blood recalcification times increased as a linear function of increasing heparin concentrations in vitro. Comparison with whole-blood clotting times revealed reasonably good correlation between the two tests. For whole-blood clotting times of 20 to 45 minutes the corresponding blood recalcification times were 142 to 212 seconds. The therapeutic range is often considered to be twice the normal range (130-270 seconds). In-vivo study revealed the peak blood recalcification time in the first sample collected 30 minutes after heparin injection, and a progressive decline thereafter to the pre-injection level during the subsequent 4 hours. The blood recalcification time is a simple, precise and clinically useful test to monitor heparin therapy.

摘要

对血液复钙时间作为一种实验室检测方法来评估并进而调节肝素抗凝作用的适用性进行了评估。血液复钙时间的正常范围为65至135秒,平均值和标准差分别为99秒和12秒。重复测定显示平均变异为5%。在体外,血液复钙时间随肝素浓度增加呈线性增加。与全血凝固时间比较显示,这两种检测方法之间有较好的相关性。对于20至45分钟的全血凝固时间,相应的血液复钙时间为142至212秒。治疗范围通常认为是正常范围的两倍(130 - 270秒)。体内研究显示,在注射肝素后30分钟采集的第一份样本中血液复钙时间达到峰值,此后在随后4小时内逐渐下降至注射前水平。血液复钙时间是监测肝素治疗的一种简单、精确且临床上有用的检测方法。

相似文献

1
Blood recalcification time. A simple and reliable test to monitor heparin therapy.血液复钙时间。一种监测肝素治疗的简单可靠的检测方法。
Am J Clin Pathol. 1976 Mar;65(3):390-6. doi: 10.1093/ajcp/65.3.390.
2
Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
J Lab Clin Med. 1971 Jun;77(6):901-7.
3
The whole blood recalcification clotting time. A suggested simple and reliable method for monitoring heparin therapy.全血再钙化凝血时间。一种建议的监测肝素治疗的简单可靠方法。
J Maine Med Assoc. 1974 Sep;65(9):211, 3.
4
Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.妇科手术中的低剂量肝素:对血液凝固试验的影响
Haemostasis. 1981;10(2):97-103. doi: 10.1159/000214392.
5
The effect of heparin on three whole blood activated clotting tests and thrombin time.肝素对三项全血活化凝血试验及凝血酶时间的影响。
ASAIO Trans. 1991 Apr-Jun;37(2):88-91.
6
Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.全血凝固时间、活化部分凝血活酶时间和全血复钙时间作为肝素监测指标。
Am J Clin Pathol. 1979 Jan;71(1):17-21. doi: 10.1093/ajcp/71.1.17.
7
Interindividual variation in relationships between plasma heparin concentration and the results of five heparin assays.血浆肝素浓度与五种肝素检测结果之间关系的个体间差异。
Clin Chim Acta. 1982 Jul 1;122(2):261-70. doi: 10.1016/0009-8981(82)90285-6.
8
Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.评估体外高频超声设备监测凝血过程的灵敏度:肝素治疗对小鼠模型影响的研究。
Ultrasound Med Biol. 2010 Feb;36(2):295-305. doi: 10.1016/j.ultrasmedbio.2009.10.010. Epub 2010 Jan 4.
9
Monitoring heparin therapy with the activated partial thromboplastin time.
Can Med Assoc J. 1971 Mar 6;104(5):385-8.
10
Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.体外循环中肝素的剂量与监测:采用亚临床血浆凝血检测技术的比较
J Thorac Cardiovasc Surg. 1990 Mar;99(3):518-27.

引用本文的文献

1
Recombinant Calreticulin Binds Complement Proteins but Does Not Protect from Complement Killing.重组钙网蛋白结合补体蛋白,但不能保护细胞免受补体杀伤。
Pathogens. 2024 Jul 3;13(7):560. doi: 10.3390/pathogens13070560.
2
New N-Methylimidazole-Functionalized Chitosan Derivatives: Hemocompatibility and Antibacterial Properties.新型N-甲基咪唑功能化壳聚糖衍生物:血液相容性和抗菌性能
Biomimetics (Basel). 2023 Jul 11;8(3):302. doi: 10.3390/biomimetics8030302.
3
LCTX-F2, a Novel Potentiator of Coagulation Factors From the Spider Venom of .
LCTX-F2,一种源自蜘蛛毒液的新型凝血因子增强剂。
Front Pharmacol. 2020 Jun 16;11:896. doi: 10.3389/fphar.2020.00896. eCollection 2020.
4
Joannsin, a novel Kunitz-type FXa inhibitor from the venom of Prospirobolus joannsi.乔安辛,一种新型 Kunitz 型 FXa 抑制剂,来源于乔氏普罗布斯蛛毒液。
Thromb Haemost. 2017 Jun 2;117(6):1031-1039. doi: 10.1160/TH16-11-0829. Epub 2017 Mar 9.
5
Does routine repeat testing of critical laboratory values improve their accuracy?对关键实验室检查值进行常规重复检测能否提高其准确性?
Med J Islam Repub Iran. 2015 Feb 9;29:176. eCollection 2015.
6
Glycoinositolphospholipids from Trypanosomatids subvert nitric oxide production in Rhodnius prolixus salivary glands.无脊椎动物中的甘油酰基肌醇磷脂干扰唾液腺中 Rhodnius prolixus 的一氧化氮的产生。
PLoS One. 2012;7(10):e47285. doi: 10.1371/journal.pone.0047285. Epub 2012 Oct 15.